Day Three: Saturday, March 10
Sessions will delve into the nuts and bolts of implementing pharmacogenetics in your practice. In these relaxed, interactive sessions, experienced early adopters of clinical pharmacogenetics will provide insight on lessons they have learned along the way, strategies to overcome common barriers, and tips for building a successful pharmacogenetics service.
Day three of the conference will continue at the UF Research and Academic Center at Lake Nona.
|8:00 – 9:00 a.m.||Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines and online resources such as PharmGKB are essential tools when developing a new pharmacogenetics service. Expert speakers will discuss their experiences using various guidelines and provide suggestions to help pave the way for a smooth road to implementation and adoption of CPIC recommendations in practice.||Kristin Weitzel, Pharm.D., CDE, FAPhA
University of Florida
J. Kevin Hicks, Pharm.D., Ph.D.
Mark Dunnenberger, Pharm.D.
|9:00 – 10:00 a.m.||Navigating your way through the rapidly growing world of commercial pharmacogenetic testing laboratories can be challenging. In this interactive session, an experienced clinician will provide a roadmap for selecting a commercial laboratory to help participants find their best path and provide answers to common questions.||Mark Dunnenberger, Pharm.D.
NorthShore University Health System
|10:00 – 10:15 a.m.|
|10:15 – 11:00 a.m.||How do you document pharmacogenetic test results and drug therapy recommendations in patient charts and/or electronic health records? And what points should you include when discussing test results with clinicians and patients? This session will provide practical answers to these and other questions to equip participants for successful implementation across a broad range of practice settings.||Gillian Bell, Pharm.D.
Mission Health System
Pharmacogenetics Patient Case Challenges: What Would You Do?
|11:00 a.m. – 12 p.m.||Experienced clinicians will present complex pharmacogenetic patient cases for panel-based discussion. These real-world scenarios will include dialogue and debate about clinical pharmacogenetics and practical issues such as test ordering, reimbursement/billing, patient education, return and documentation of test results, liability concerns, and more. Attendees will be able to actively participate to ensure that they are able to apply newly acquired skills upon their return to practice.||J. Kevin Hicks, Pharm.D., Ph.D.
Moffitt Cancer Center
Kristin Weitzel, Pharm.D., CDE, FAPhA
Max Smith III, Pharm.D., BCPS